|
American Academy of Pediatrics Work Group on Cord Blood
Banking. Cord blood banking for potential future transplantation. Pediatrics. 1999;
104:116-188.
Centers for Disease Control, National Center for Infectious
Diseases. Epstein Barr Virus and Infectious Mononucleosis. Accessed at
www.cdc.gov/ncidod/diseases/ebv.htm on May 7, 2009.
Champlin R. Hematopoietic cellular transplantation. In: Kufe
DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei
E, eds. Cancer Medicine.
6th ed. Hamilton, Ontario:BC, Decker Inc.; 2003:1019-1036.
Childs RW. Allogeneic stem cell transplantation. In: DeVita
VT, Hellman S, Rosenberg SA, eds. Cancer:
Principles and Practice of Oncology. 6th ed. Philadelphia,
Pa: Lippincott Williams & Wilkins; 2001:2779-2797.
Cooper DL, Seropian S. Autologous stem cell transplantation.
In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice
of Oncology. 6th ed. Philadelphia, Pa: Lippincott Williams
& Wilkins; 2001:2767-2778.
Gallagher G, Forrest DL. Second Solid Cancers After Allogeneic
Hematopoietic Stem Cell Transplantation. Cancer. 2007;
109:84-92.
International Cord Blood Society. Cord Blood Banking. Accessed
at www.cordblood.org/index.htm on May 7, 2009.
Multiple Myeloma Research Foundation. Tandem Autologous
Transplants. Accessed at www.multiplemyeloma.org/treatments/3.03.03.php
on May 7, 2009.
National Cancer Institute. Bone Marrow Transplantation and
Peripheral Blood Stem Cell Transplantation. Accessed at
www.cancer.gov/cancertopics/factsheet/Therapy/bone-marrow-transplant on
May 7, 2009.
National Marrow Donor Program. Accessed at www.marrow.org/ on
May 7, 2009.
Peters WP, Dansey R, Baynes RD. Autologous bone marrow and
stem cell transplantation. In: Kufe DW, Pollock RE, Weichselbaum RR,
Bast RC, Gansler TS, Holland JF, Frei E, eds. Cancer Medicine.
6th ed. Hamilton, Ontario: BC, Decker Inc.; 2003:999-1018.
Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, et.al.
Nonmalignant late effects after allogeneic stem cell transplantation. Blood.
2003;101:3373-3385.
Sundin M, Le Blanc K, Ringden O, Barkholt L, Omazic B, et.al.
The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus
seronegativity as risk factors in post-transplant lymphoproliferative
disorder following allogeneic hematopoietic stem cell transplantation. Haematologica/The Hematology
Journal. 2006;91:1059-1067.
Zamkoff KW, Bergman S, Beaty MW, Buss DH, Pettenati MJ, Hurd
DD. Fatal EBV-related post-transplant lymphoproliferative disorder
(LPD) after matched related donor nonmyeloablative peripheral blood
progenitor cell transplant. Bone
Marrow Transplantation. 2003; 31:219-222.
Last Medical Review: 05/27/2009
Last Revised: 05/27/2009
|
